Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Molecular Therapy. Methods & Clinical Development|August 30, 2023
Gene replacement therapy in two Golgi-retained CMT1X mutants before and after the onset of demyelinating neuropathyAlexia Kagiava, Christos Karaiskos, George Lapathitis, et al.
Acta Neuropathologica Communications|September 3, 2016
Systemic inflammation disrupts oligodendrocyte gap junctions and induces ER stress in a model of CNS manifestations of X-linked Charcot-Marie-Tooth diseaseMargarita Olympiou, Irene Sargiannidou, Kyriaki Markoullis, et al.
Plos One|October 24, 2012
The bite of the honeybee: 2-heptanone secreted from honeybee mandibles during a bite acts as a local anaesthetic in insects and mammalsAlexandros Papachristoforou, Alexia Kagiava, Chrisovalantis Papaefthimiou, et al.
Gene Therapy|May 12, 2026
A dose-escalation and safety gene therapy study in a model of CMT4C neuropathyElena Georgiou, Alexia Kagiava, Andreas Hentschel, et al.
Brain : a Journal of Neurology|January 20, 2017
Gene therapy targeting oligodendrocytes provides therapeutic benefit in a leukodystrophy modelElena Georgiou, Kyriaki Sidiropoulou, Jan Richter, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2016
Intrathecal gene therapy rescues a model of demyelinating peripheral neuropathyAlexia Kagiava, Irene Sargiannidou, George Theophilidis, et al.
International Journal of Molecular Sciences|November 13, 2021
Aberrant Mitochondrial Dynamics and Exacerbated Response to Neuroinflammation in a Novel Mouse Model of CMT2AFilippos Stavropoulos, Irene Sargiannidou, Louiza Potamiti, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 29, 2023
AAV9-mediated SH3TC2 gene replacement therapy targeted to Schwann cells for the treatment of CMT4CElena Georgiou, Alexia Kagiava, Irene Sargiannidou, et al.
Frontiers in Immunology|September 12, 2022
Pharmacological activation of the C5a receptor leads to stimulation of the β-adrenergic receptor and alleviates cognitive impairment in a murine model of familial Alzheimer's diseaseEleni Fella, Revekka Papacharalambous, Demos Kynigopoulos, et al.
Gene Therapy|March 11, 2021
AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathyAlexia Kagiava, Christos Karaiskos, Jan Richter, et al.
Pageof 4